Submitted:
26 December 2024
Posted:
27 December 2024
You are already at the latest version
Abstract
Keywords:
Introduction
The Role of the Gut Microbiome in Metabolic Syndrome
Dietary Strategies to Enhance Gut Microbiome Health
Postbiotics and Their Role in Metabolic Health
Innovative Supplements for Metabolic Syndrome
1. Probiotic and Prebiotic Supplements
2. Omega-3 Fatty Acids
3. Polyphenols and Antioxidants
4. Berberine
Conclusion
References
- Aleixandre, A.; Miguel, M. Dietary Fiber in the Prevention and Treatment of Metabolic Syndrome: A Review. Crit. Rev. Food Sci. Nutr. 2008, 48, 905–912. [Google Scholar] [CrossRef] [PubMed]
- Ambroselli, D.; Masciulli, F.; Romano, E.; Catanzaro, G.; Besharat, Z.M.; Massari, M.C.; Ferretti, E.; Migliaccio, S.; Izzo, L.; Ritieni, A.; et al. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food. Nutrients 2023, 15, 640. [Google Scholar] [CrossRef] [PubMed]
- Andersen, C.J.; Fernandez, M.L. Dietary strategies to reduce metabolic syndrome. Rev. Endocr. Metab. Disord. 2013, 14, 241–254. [Google Scholar] [CrossRef]
- Cani, P.D. , Van Hul, M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr. Opin. Biotechnol. 2015, 32, 21–27. [Google Scholar]
- Castro-Barquero, S.; Ruiz-León, A.M.; Sierra-Pérez, M.; Estruch, R.; Casas, R. Dietary Strategies for Metabolic Syndrome: A Comprehensive Review. Nutrients 2020, 12, 2983. [Google Scholar] [CrossRef]
- Chan, M.; Larsen, N.; Baxter, H.; Jespersen, L.; Ekinci, E.I.; Howell, K. The impact of botanical fermented foods on metabolic syndrome and type 2 diabetes: a systematic review of randomised controlled trials. Nutr. Res. Rev. 2023, 37, 396–415. [Google Scholar] [CrossRef]
- Chiva-Blanch, G.; Badimon, L. Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials. Oxidative Med. Cell. Longev. 2017, 2017, 5812401–5812401. [Google Scholar] [CrossRef]
- Croci, S.; D’apolito, L.I.; Gasperi, V.; Catani, M.V.; Savini, I. Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites. Nutrients 2021, 13, 1389. [Google Scholar] [CrossRef]
- Şanlier, N.; Gökcen, B.B.; Sezgin, A.C. Health benefits of fermented foods. Crit. Rev. Food Sci. Nutr. 2019, 59, 506–527. [Google Scholar] [CrossRef]
- Dabke, K.; Hendrick, G.; Devkota, S. The gut microbiome and metabolic syndrome. J. Clin. Investig. 2019, 129, 4050–4057. [Google Scholar] [CrossRef]
- Deehan, E.C.; Mocanu, V.; Madsen, K.L. Effects of dietary fibre on metabolic health and obesity. Nat. Rev. Gastroenterol. Hepatol. 2024, 21, 301–318. [Google Scholar] [CrossRef] [PubMed]
- e Oliveira Ribeiro G, da Costa AC, Gill DE, Ribeiro ESD, Rego MODS, Monteiro FJC, Villanova F, Nogueira JS, Maeda AY, de Souza RP, Tahmasebi R, Morais VS, Pandey RP, Raj VS, Scandar SAS, da Silva Vasami FG, D'Agostino LG, Maiorka PC, Deng X, Nogueira ML, Sabino EC, Delwart E, Leal É, Cunha MS. Guapiaçu virus, a new insect-specific flavivirus isolated from two species of Aedes mosquitoes from Brazil. Sci Rep. 2021 Feb 25;11(1):4674.
- Dhakal, D.; Han, J.M.; Mishra, R.; Pandey, R.P.; Kim, T.-S.; Rayamajhi, V.; Jung, H.J.; Yamaguchi, T.; Sohng, J.K. Characterization of Tailoring Steps of Nargenicin A1 Biosynthesis Reveals a Novel Analogue with Anticancer Activities. ACS Chem. Biol. 2020, 15, 1370–1380. [Google Scholar] [CrossRef] [PubMed]
- Festi, D.; Schiumerini, R.; Eusebi, L.H.; Marasco, G.; Taddia, M.; Colecchia, A. Gut microbiota and metabolic syndrome. World J. Gastroenterol. 2014, 20, 16079–94. [Google Scholar] [CrossRef]
- Gunjan, J.; Vidic, J.; Manzano, M.; Raj, V.S.; Pandey, R.P.; Chang, C.-M. Comparative meta-analysis of antimicrobial resistance from different food sources along with one health approach in Italy and Thailand. One Heal. 2022, 16, 100477. [Google Scholar] [CrossRef]
- He, M.; Shi, B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017, 7, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Hur, K.Y.; Lee, M.-S. Gut Microbiota and Metabolic Disorders. Diabetes Metab. J. 2015, 39, 198–203. [Google Scholar] [CrossRef]
- Himanshu; Prudencio, C. R.; da Costa, A.C.; Leal, E.; Chang, C.-M.; Pandey, R.P. Systematic Surveillance and Meta-Analysis of Antimicrobial Resistance and Food Sources from China and the USA. Antibiotics 2022, 11, 1471. [Google Scholar] [CrossRef]
- Ikram, M.; Mahmud, M.A.P. Advanced triboelectric nanogenerator-driven drug delivery systems for targeted therapies. Drug Deliv. Transl. Res. 2022, 13, 54–78. [Google Scholar] [CrossRef]
- Jang, H.; Park, K. Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: A systematic review and meta-analysis. Clin. Nutr. 2020, 39, 765–773. [Google Scholar] [CrossRef]
- Khatri, P.; Rani, A.; Hameed, S.; Chandra, S.; Chang, C.-M.; Pandey, R.P. Current Understanding of the Molecular Basis of Spices for the Development of Potential Antimicrobial Medicine. Antibiotics 2023, 12, 270. [Google Scholar] [CrossRef]
- Kim, M.-J.; Kim, J.-I.; Ryu, C.-H.; Kang, M.-J. Effects of Fermented Beverage in Subjects with Metabolic Syndrome. Prev. Nutr. Food Sci. 2021, 26, 12–20. [Google Scholar] [CrossRef] [PubMed]
- Konyak, B.M.; Sharma, M.; Kharia, S.; Pandey, R.P.; Chang, C.-M. A Systematic Review on the Emergence of Omicron Variant and Recent Advancement in Therapies. Vaccines 2022, 10, 1468. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.; Kim, T.-S.; Parajuli, P.; Pandey, R.P.; Sohng, J.K. Sustainable Production of Dihydroxybenzene Glucosides Using Immobilized Amylosucrase from Deinococcus geothermalis. J. Microbiol. Biotechnol. 2018, 28, 1447–1456. [Google Scholar] [CrossRef]
- Marrone, G.; Guerriero, C.; Palazzetti, D.; Lido, P.; Marolla, A.; Di Daniele, F.; Noce, A. Vegan Diet Health Benefits in Metabolic Syndrome. Nutrients 2021, 13, 817. [Google Scholar] [CrossRef]
- Mazidi, M.; Rezaie, P.; Kengne, A.P.; Mobarhan, M.G.; Ferns, G.A. Gut microbiome and metabolic syndrome. Diabetes Metab. Syndr. Clin. Res. Rev. 2016, 10, S150–S157. [Google Scholar] [CrossRef]
- Mohamed, S.M.; Shalaby, M.A.; El-Shiekh, R.A.; El-Banna, H.A.; Emam, S.R.; Bakr, A.F. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem. Adv. 2023, 3. [Google Scholar] [CrossRef]
- Och, A.; Och, M.; Nowak, R.; Podgórska, D.; Podgórski, R. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules 2022, 27, 1351. [Google Scholar] [CrossRef]
- Pandey, R.P.; Nascimento, M.S.; Franco, C.H.; Bortoluci, K.; Silva, M.N.; Zingales, B.; Gibaldi, D.; Barrios, L.C.; Lannes-Vieira, J.; Cariste, L.M.; et al. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo. Antimicrob. Agents Chemother. 2022, 66, e0028422. [Google Scholar] [CrossRef]
- Pandey, R.P.; Mukherjee, R.; Chang, C.-M. Antimicrobial resistance surveillance system mapping in different countries. Drug Target Insights 2022, 16, 36–48. [Google Scholar] [CrossRef]
- Pandey, R.P.; Mukherjee, R.; Chang, C.-M. Emerging Concern with Imminent Therapeutic Strategies for Treating Resistance in Biofilm. Antibiotics 2022, 11, 476. [Google Scholar] [CrossRef]
- Pandey, R.P.; Gunjan; Himanshu; Mukherjee, R. ; Chang, C.-M. Nanocarrier-mediated probiotic delivery: a systematic meta-analysis assessing the biological effects. Sci. Rep. 2024, 14, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Ristic-Medic, D. , Vucic, V. Dietary fats and metabolic syndrome. J Nutr Heal. Food Sci 2013, 1, 8. [Google Scholar]
- Shu, L.; Zhang, X.; Zhou, J.; Zhu, Q.; Si, C. Ultra-processed food consumption and increased risk of metabolic syndrome: a systematic review and meta-analysis of observational studies. Front. Nutr. 2023, 10, 1211797. [Google Scholar] [CrossRef]
- Martínez Steele, E.; Juul, F.; Neri, D.; Rauber, F.; Monteiro, C.A. Dietary Share of Ultra-Processed Foods and Metabolic Syndrome in the US Adult Population. Prev. Med. 2019, 125, 40–48. [Google Scholar] [CrossRef]
- Tabeshpour, J.; Imenshahidi, M.; Hosseinzadeh, H. A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. 2017, 20, 557–568. [CrossRef]
- Tenorio-Jiménez, C.; Martínez-Ramírez, M.J.; Gil, Á.; Gómez-Llorente, C. Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials. Nutrients 2020, 12, 124. [Google Scholar] [CrossRef]
- Wang, P.-X.; Deng, X.-R.; Zhang, C.-H.; Yuan, H.-J. Gut microbiota and metabolic syndrome. Chin. Med J. 2020, 133, 808–816. [Google Scholar] [CrossRef]
- Yoo, J.Y.; Kim, S.S. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients 2016, 8, 173. [Google Scholar] [CrossRef]
| Aspect of Metabolic Syndrome | Role of the Gut Microbiome | Mechanisms of Action |
|---|---|---|
| Obesity | Gut microbiota composition is linked to obesity risk | Dysbiosis (imbalance of gut microbiota) may lead to increased energy extraction from food and altered fat storage. Certain bacteria (e.g., Firmicutes) are associated with higher energy harvest from food, contributing to weight gain. |
| Insulin Resistance | Gut microbiota affects insulin sensitivity | Altered gut microbiome can influence insulin resistance by increasing inflammation, producing metabolites like short-chain fatty acids (SCFAs) that improve insulin function, or modifying bile acid metabolism. |
| High Blood Pressure | Gut microbiota may influence blood pressure regulation | Imbalance in gut microbiota can lead to increased production of endotoxins that promote inflammation and hypertension. Gut-produced SCFAs can help regulate blood pressure by affecting vascular tone and sodium balance. |
| Dyslipidemia | Microbiota affects lipid metabolism | Gut bacteria can influence lipid metabolism, bile acid synthesis, and fat absorption. Dysbiosis can result in elevated LDL cholesterol, triglycerides, and low HDL cholesterol. Beneficial bacteria like Lactobacillus and Bifidobacterium may help improve lipid profiles. |
| Inflammation | Dysbiosis promotes chronic low-grade inflammation | An imbalance in gut microbiota increases gut permeability ("leaky gut"), allowing endotoxins to enter the bloodstream, triggering systemic inflammation. This inflammation contributes to metabolic dysfunction and metabolic syndrome. |
| Fatty Liver Disease (NAFLD) | Gut microbiota plays a role in liver health | The gut microbiome can influence liver fat accumulation and inflammation. Dysbiosis may promote the development of fatty liver disease by enhancing intestinal permeability and causing an inflammatory response in the liver. |
| Endotoxemia | Gut microbiota contributes to endotoxin production | Imbalanced gut microbiota, especially with an overgrowth of gram-negative bacteria, can lead to the production of lipopolysaccharides (LPS), which are pro-inflammatory and contribute to metabolic syndrome. |
| Gut-Brain Axis | Gut microbiome influences appetite and metabolism through the gut-brain axis | Gut microbiota affects the release of appetite-regulating hormones such as ghrelin and leptin, influencing hunger and satiety signals. Altered microbiota can disrupt these signals, contributing to overeating and obesity. |
| Short-Chain Fatty Acids (SCFAs) | SCFAs produced by gut microbiota are beneficial for metabolic health | SCFAs (e.g., acetate, propionate, butyrate) help regulate glucose metabolism, reduce inflammation, and improve insulin sensitivity. SCFAs are produced by the fermentation of dietary fibers by beneficial gut bacteria. |
| Bile Acid Metabolism | Gut microbiome regulates bile acid metabolism | Gut bacteria modify bile acids, influencing fat digestion and absorption. Altered bile acid metabolism can affect lipid metabolism, insulin sensitivity, and the development of metabolic diseases. |
| Microbial Diversity | Greater microbial diversity is associated with better metabolic health | Higher microbial diversity is linked to a healthier metabolic profile, better immune function, and reduced inflammation. Low diversity is often associated with obesity, insulin resistance, and dyslipidemia. |
| Dietary Strategy | Food Sources | Mechanisms of Action | Impact on Metabolic Syndrome |
|---|---|---|---|
| Increase Fiber Intake | Whole grains (e.g., oats, quinoa), legumes (e.g., beans, lentils), fruits (e.g., apples, berries), vegetables (e.g., broccoli, spinach), nuts, seeds | Fibre serves as a prebiotic, feeding beneficial gut bacteria and promoting the production of short-chain fatty acids (SCFAs). | It improves insulin sensitivity, supports weight management, and helps reduce inflammation, all key factors in managing metabolic syndrome. |
| Incorporate Prebiotics | Garlic, onions, leeks, asparagus, bananas, chicory, artichokes | Prebiotics stimulate the growth of beneficial gut bacteria, supporting microbial diversity and SCFA production. | Enhances gut health, lowers inflammation, and supports better metabolic control. |
| Consume Fermented Foods | Yogurt, kefir, sauerkraut, kimchi, miso, kombucha, pickles | Fermented foods contain probiotics that introduce beneficial bacteria to the gut, improving microbial balance and digestion. | Enhances gut microbiota, boosts immunity, and may help lower cholesterol and blood pressure. |
| Add Polyphenol-Rich Foods | Berries, apples, dark chocolate, green tea, olive oil, red wine, nuts (e.g., almonds, walnuts) | Polyphenols support the growth of beneficial bacteria and help reduce harmful bacterial growth, promoting anti-inflammatory effects. | Reduces oxidative stress, supports heart health, and improves lipid profiles, reducing metabolic syndrome risks. |
| Consume Omega-3 Fatty Acids | Fatty fish (e.g., salmon, mackerel), chia seeds, flaxseeds, walnuts | Omega-3s promote the growth of anti-inflammatory gut bacteria and help regulate gut function. | Reduces systemic inflammation, supports better lipid metabolism, and improves insulin sensitivity. |
| Limit Processed Foods & Added Sugars | Refined sugars, sugary drinks, processed snacks, fast food | High consumption of processed foods and added sugars disrupts gut microbiota and promotes harmful bacteria, leading to inflammation and metabolic disturbances. | Reduces the risk of obesity, insulin resistance, and dyslipidemia associated with metabolic syndrome. |
| Moderate Animal Protein & Fat | Red meat, processed meats, fatty cuts of meat | Excessive animal protein and fat intake can lead to an imbalance in gut microbiota, promoting inflammation and metabolic dysfunction. | Helps prevent weight gain, insulin resistance, and dyslipidemia by supporting a balanced gut microbiome. |
| Increase Plant-Based Foods | Vegetables, fruits, whole grains, legumes, nuts, seeds | Plant-based foods are rich in fiber, antioxidants, and polyphenols that nurture a diverse microbiome and enhance overall gut health. | Supports weight management, improves insulin sensitivity, and reduces inflammation, all key to preventing metabolic syndrome. |
| Include Resistant Starch | Cooked and cooled potatoes, pasta, rice, green bananas, legumes | Resistant starch feeds beneficial gut bacteria, enhancing SCFA production and gut health. | Improves insulin sensitivity, supports healthy blood sugar levels, and aids in weight management. |
| Hydrate Well | Water, herbal teas, soups | Proper hydration supports digestion and gut motility, maintaining gut microbiota balance. | Promotes healthy digestion, enhances nutrient absorption, and helps regulate metabolic processes. |
| Avoid Excessive Alcohol | N/A (Moderation or avoidance of alcohol) | Excessive alcohol disrupts gut microbiota and increases gut permeability, leading to inflammation and metabolic disturbances. | Reduces risk of liver disease, insulin resistance, and inflammation associated with metabolic syndrome. |
| Diverse Diet | A variety of fruits, vegetables, whole grains, legumes, nuts, seeds, and lean proteins | A diverse diet promotes the growth of a diverse microbiome, which is linked to better overall health and metabolic function. | Enhances metabolic flexibility, reduces inflammation, and supports weight management, all crucial for managing metabolic syndrome. |
| Use Bone Broth | Bone broth, collagen-rich foods | Bone broth supports gut barrier integrity and reduces gut permeability, helping maintain a healthy microbiome. | Supports gut health and immune function, improving overall metabolic markers. |
| Supplement | Key Ingredients | Potential Benefits | Mechanisms of Action |
|---|---|---|---|
| Probiotics | Lactobacillus, Bifidobacterium, Saccharomyces | Improves gut microbiome health, enhances insulin sensitivity, reduces inflammation, aids weight management | Probiotics restore gut microbiota balance, enhance SCFA production, and reduce systemic inflammation, which improves metabolic markers like blood sugar and lipid profiles. |
| Berberine | Berberine extract (from Berberis species) | Improves insulin sensitivity, reduces blood sugar and lipids, supports weight loss | Berberine activates AMP-activated protein kinase (AMPK), improving insulin sensitivity, glucose metabolism, and lipid regulation. |
| Curcumin | Curcumin (from turmeric) | Reduces inflammation, improves insulin sensitivity, supports liver health | Curcumin has potent anti-inflammatory effects, reduces oxidative stress, and modulates metabolic pathways linked to insulin resistance and fat metabolism. |
| Omega-3 Fatty Acids | Fish oil (EPA, DHA), Algal oil | Reduces inflammation, improves blood lipids, supports cardiovascular health | Omega-3 fatty acids reduce systemic inflammation, lower triglycerides, improve HDL cholesterol, and enhance insulin sensitivity. |
| Alpha-Lipoic Acid (ALA) | Alpha-lipoic acid | Improves insulin sensitivity, reduces oxidative stress, supports weight management | ALA acts as an antioxidant, reduces oxidative damage, enhances glucose uptake, and improves lipid metabolism, helping to reduce risk factors of metabolic syndrome. |
| Cinnamon Extract | Cinnamon polyphenols (Cinnamomum cassia) | Lowers blood sugar, improves insulin sensitivity, reduces inflammation | Cinnamon increases insulin receptor sensitivity and enhances glucose uptake in cells, contributing to better blood sugar control. |
| Chromium Picolinate | Chromium (elemental form) | Improves blood glucose regulation, enhances insulin sensitivity | Chromium plays a role in enhancing insulin action, improving glucose uptake, and stabilizing blood sugar levels. |
| Magnesium | Magnesium citrate, magnesium glycinate | Improves insulin sensitivity, supports blood pressure regulation, aids sleep | Magnesium helps regulate glucose metabolism, supports endothelial function, and improves insulin sensitivity, which is crucial for metabolic syndrome management. |
| Coenzyme Q10 (CoQ10) | CoQ10 (ubiquinone) | Supports mitochondrial function, reduces oxidative stress, improves heart health | CoQ10 boosts cellular energy production, reduces inflammation, and protects against oxidative damage, improving overall metabolic function and cardiovascular health. |
| Vitamin D | Vitamin D3 (cholecalciferol) | Improves insulin sensitivity, supports immune function, regulates blood pressure | Vitamin D plays a role in calcium metabolism, insulin sensitivity, and immune function, while deficiencies are linked to metabolic dysfunction and increased risk of diabetes. |
| L-Carnitine | L-Carnitine (from animal or plant sources) | Supports fat metabolism, improves exercise performance, aids in weight loss | L-Carnitine transports fatty acids into mitochondria for energy production, aiding fat oxidation and helping with weight management. |
| Fiber Supplements | Psyllium husk, inulin, glucomannan | Reduces blood sugar, improves gut health, supports weight loss | Fiber supplements improve gut motility, help regulate blood sugar levels, and promote satiety, which aids in weight loss and reduces risk factors for metabolic syndrome. |
| Green Tea Extract | Epigallocatechin gallate (EGCG) | Increases fat oxidation, improves insulin sensitivity, supports weight loss | EGCG in green tea increases thermogenesis, fat oxidation, and enhances insulin sensitivity, which helps in reducing body fat and improving metabolic health. |
| Resveratrol | Resveratrol (from grapes, red wine) | Reduces inflammation, improves insulin sensitivity, supports cardiovascular health | Resveratrol acts as an antioxidant and anti-inflammatory, improving endothelial function, reducing oxidative stress, and enhancing insulin sensitivity. |
| Garlic Extract | Allicin, sulfur compounds | Reduces blood pressure, improves cholesterol levels, supports weight loss | Garlic extract has anti-inflammatory properties, reduces blood pressure, and improves lipid profiles, contributing to improved metabolic health. |
| Ashwagandha | Withanolides (from Withania somnifera) | Reduces stress, improves insulin sensitivity, supports weight management | Ashwagandha modulates cortisol levels, reducing stress-related fat accumulation and inflammation while improving glucose metabolism and insulin sensitivity. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
